Anthony Chibuogwu Ike
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthony Chibuogwu Ike has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Chukwuemeka Samson Ahamefule
University of Nigeria
4 shared publications - Sophia O. Muo
Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu 410001, Nigeria
3 shared publications - Anene Nwabu Moneke
University of Nigeria
2 shared publications - Chisom Onu
Department of Biological Sciences, Wayne State University
2 shared publications - Chukwuebuka M. Ononugbo
Department of Biotechnology, Graduate School of Engineering, Osaka University, Suita City, Osaka 565-0871, Japan
2 shared publications - Eleazar E. Reward
Department of Biological Sciences, Wayne State University, Detroit, MI 48202, USA
2 shared publications
Latest Publications
- 16 February 2026
- Published by Taylor & Francis in Innovation: The European Journal of Social Science Research
- Vol. 39 (4) , 2020-2042
Understanding social media-mediated myths about COVID-19 in Nigeria
- 16 February 2026
- Published by Taylor & Francis in Innovation: The European Journal of Social Science Research
- Vol. 39 (4) , 2020-2042
Understanding social media-mediated myths about COVID-19 in Nigeria
- Open Access
- 29 May 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-7
Molecular epidemiology of hepatitis B virus from blood samples obtained from persons in Enugu and Nasarawa States, Nigeria
Hepatitis B virus (HBV) infection remains a major global health concern, with a high burden in countries like Nigeria. This study aimed to investigate the molecular epidemiology of HBV by identifying circulating genotypes and detecting antiviral-resistant mutations in samples from selected communities in Enugu and Nasarawa States, Nigeria. Sample (plasma and serum) quality was evaluated after prolonged storage under freeze-thaw conditions using Qubit 4 fluorometer and Nanodrop One spectrophotometer. High-quality samples underwent molecular characterization and Sanger sequencing for HBV-positive cases. Of the 67 samples analyzed, seven were sequenced: two from Enugu and four from Nasarawa belonged to genotype E, while one from Nasarawa was genotype A. No antiviral resistance mutations were identified. This study provides valuable molecular data contributing to our understanding of HBV epidemiology in Nigeria.
- 29 May 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-7
Open AccessMolecular epidemiology of hepatitis B virus from blood samples obtained from persons in Enugu and Nasarawa States, Nigeria
Hepatitis B virus (HBV) infection remains a major global health concern, with a high burden in countries like Nigeria. This study aimed to investigate the molecular epidemiology of HBV by identifying circulating genotypes and detecting antiviral-resistant mutations in samples from selected communities in Enugu and Nasarawa States, Nigeria. Sample (plasma and serum) quality was evaluated after prolonged storage under freeze-thaw conditions using Qubit 4 fluorometer and Nanodrop One spectrophotometer. High-quality samples underwent molecular characterization and Sanger sequencing for HBV-positive cases. Of the 67 samples analyzed, seven were sequenced: two from Enugu and four from Nasarawa belonged to genotype E, while one from Nasarawa was genotype A. No antiviral resistance mutations were identified. This study provides valuable molecular data contributing to our understanding of HBV epidemiology in Nigeria.
- Open Access
- 16 October 2024
- Published by Elsevier in Current Research in Microbial Sciences
- Vol. 7, 100293
Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases
- 16 October 2024
- Published by Elsevier in Current Research in Microbial Sciences
- Vol. 7, 100293
Open AccessAntiseptics: An expeditious third force in the prevention and management of coronavirus diseases
- Open Access
COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis
Widespread COVID-19 vaccination is essential to maintaining pandemic control. However, low- and lower-middle-income countries (LMICs) continue to face challenges to care due to unequal access and vaccine fear despite the introduction of safe and effective immunizations. This study aimed to collect information on Nigeria’s COVID-19 vaccine uptake rates and determinants. Science Direct, PubMed, Google Scholar, African Journal Online, Springer, and Hinari were all systematically searched through and completed in May 2022. Quality assessments of the listed studies were performed using the eight-item Joanna Briggs Institute Critical Appraisal tools for cross-sectional studies. In addition, we undertook a meta-analysis to calculate pooled acceptance rates with 95% confidence intervals (CI). Forty-two studies in total satisfied the inclusion criteria and were reviewed. A total of 24,533 respondents were studied. The total sample size of states in the Northern, Western and Southern parts of Nigeria are 3,206, 4,527 and 5,059, respectively, while 11,741 is the cumulative sample size of all the Nigeria-wide studies. The total COVID-19 vaccination acceptance rate among all the study groups was 52.4% (95% CI: 46.9-57.9%, I 2 = 100%), while the total estimated COVID-19 vaccination hesitancy rates was 47.81% (95% CI: 42.2 – 53.4% I 2 = 100%). In Nigeria-regions sub-group analyses, the Western region (58.90%, 95% CI: 47.12–70.27%) and Northern region (54.9%, 95% CI: 40.11%–69.4%) showed the highest rates of vaccine acceptance and vaccine hesitancy respectively. The COVID-19 vaccine acceptance rate was highest in 2020, with a pooled rate of 59.56% (46.34, 57.32%, I 2 = 98.7%). The acceptance rate in 2021 was only 48.48 (40.78%, 56.22%), while for the studies in 2022, it increased to 52.04% (95% CI: 35.7%, 68.15 %). The sensitization of local authorities and the dissemination of more detailed information about the COVID-19 vaccine and its safety, could significantly increase the country’s vaccination rate.
Open AccessCOVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis
Widespread COVID-19 vaccination is essential to maintaining pandemic control. However, low- and lower-middle-income countries (LMICs) continue to face challenges to care due to unequal access and vaccine fear despite the introduction of safe and effective immunizations. This study aimed to collect information on Nigeria’s COVID-19 vaccine uptake rates and determinants. Science Direct, PubMed, Google Scholar, African Journal Online, Springer, and Hinari were all systematically searched through and completed in May 2022. Quality assessments of the listed studies were performed using the eight-item Joanna Briggs Institute Critical Appraisal tools for cross-sectional studies. In addition, we undertook a meta-analysis to calculate pooled acceptance rates with 95% confidence intervals (CI). Forty-two studies in total satisfied the inclusion criteria and were reviewed. A total of 24,533 respondents were studied. The total sample size of states in the Northern, Western and Southern parts of Nigeria are 3,206, 4,527 and 5,059, respectively, while 11,741 is the cumulative sample size of all the Nigeria-wide studies. The total COVID-19 vaccination acceptance rate among all the study groups was 52.4% (95% CI: 46.9-57.9%, I 2 = 100%), while the total estimated COVID-19 vaccination hesitancy rates was 47.81% (95% CI: 42.2 – 53.4% I 2 = 100%). In Nigeria-regions sub-group analyses, the Western region (58.90%, 95% CI: 47.12–70.27%) and Northern region (54.9%, 95% CI: 40.11%–69.4%) showed the highest rates of vaccine acceptance and vaccine hesitancy respectively. The COVID-19 vaccine acceptance rate was highest in 2020, with a pooled rate of 59.56% (46.34, 57.32%, I 2 = 98.7%). The acceptance rate in 2021 was only 48.48 (40.78%, 56.22%), while for the studies in 2022, it increased to 52.04% (95% CI: 35.7%, 68.15 %). The sensitization of local authorities and the dissemination of more detailed information about the COVID-19 vaccine and its safety, could significantly increase the country’s vaccination rate.
- 15 February 2023
- Published by Springer Nature in Current Microbiology
- Vol. 80 (4) , 1-9
Juxtaposing Caenorhabditis elegans-Pathogenic Mould Model with Other Models; How Reliable Is This Nematode Model? A Mini Review
The application of Caenorhabditis elegans as a pathogenic model has spanned decades. Its use for pathogenic mould modeling has been attracting some attention lately, though not without some reservations. Several studies have shown C. elegans to be a reliable model for evaluating moulds’ virulence factors and patterns as well as for screening the pathogenicity of mutant strains alongside their parental/wild type and revertant/complementary strains. There is a very high degree of reported similarities between the virulence patterns demonstrated in C. elegans and those of other invertebrate and vertebrate models. We have here presented several works in which this nematode model was adopted for virulence evaluation, and other comparative research in which virulence in C. elegans model were juxtaposed with other models. We have further presented possible reasons why there might have been variations of virulence in a few cases, thereby validating C. elegans to be an effective and reliable tool in the study of pathogenic moulds.
- 15 February 2023
- Published by Springer Nature in Current Microbiology
- Vol. 80 (4) , 1-9
Juxtaposing Caenorhabditis elegans-Pathogenic Mould Model with Other Models; How Reliable Is This Nematode Model? A Mini Review
The application of Caenorhabditis elegans as a pathogenic model has spanned decades. Its use for pathogenic mould modeling has been attracting some attention lately, though not without some reservations. Several studies have shown C. elegans to be a reliable model for evaluating moulds’ virulence factors and patterns as well as for screening the pathogenicity of mutant strains alongside their parental/wild type and revertant/complementary strains. There is a very high degree of reported similarities between the virulence patterns demonstrated in C. elegans and those of other invertebrate and vertebrate models. We have here presented several works in which this nematode model was adopted for virulence evaluation, and other comparative research in which virulence in C. elegans model were juxtaposed with other models. We have further presented possible reasons why there might have been variations of virulence in a few cases, thereby validating C. elegans to be an effective and reliable tool in the study of pathogenic moulds.
- Open Access
Predictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria
Healthcare workers (HCWs) are regarded as role models regarding health-related issues, including vaccination. Therefore, it is essential to identify the predictors for COVID-19 vaccine acceptance among them. A cross-sectional study to assess the risk perception, attitudes and knowledge of HCWs toward COVID-19 vaccination was carried out. A total of 710 responses were received between September 2021 and March 2022, from HCWs in the Northern, Western and Eastern regions of Nigeria. Cross tabulations were performed to determine statistical relations between sociodemographic variables, knowledge, attitudes and risk perceptions concerning COVID-19 vaccine acceptance. Multinomial logistic regression analysis was performed to determine the predictive variables for COVID-19 vaccine acceptance. Statistical analyses were performed and P-values less than 0.05 were considered statistically significant at a CI of 95%. Results showed that 59.3% of the participants were amenable to COVID-19 vaccines. Multinomial regression analysis identified 14 variables at α < 0.05 as predictors for vaccine acceptance. Male HCWs were 2.8 times more likely to accept the vaccine than their female counterparts. HCWs that were knowledgeable of the different kinds of vaccines, were willing to recommend the vaccines to their patients, believed that the timing of COVID-19 vaccination was appropriate and had recent vaccination history within three years were 1.6, 24.9, 4.4 and 3.1 times more likely to take COVID-19 vaccine than those not sure. The study found a relatively high trust (51.3%) in the Nigerian Center for Disease Control (NCDC) for information regarding COVID-19 vaccines. Therefore, the NDCD should disseminate more robust insights regarding the safety profiles of various COVID-19 vaccines.
Open AccessPredictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria
Healthcare workers (HCWs) are regarded as role models regarding health-related issues, including vaccination. Therefore, it is essential to identify the predictors for COVID-19 vaccine acceptance among them. A cross-sectional study to assess the risk perception, attitudes and knowledge of HCWs toward COVID-19 vaccination was carried out. A total of 710 responses were received between September 2021 and March 2022, from HCWs in the Northern, Western and Eastern regions of Nigeria. Cross tabulations were performed to determine statistical relations between sociodemographic variables, knowledge, attitudes and risk perceptions concerning COVID-19 vaccine acceptance. Multinomial logistic regression analysis was performed to determine the predictive variables for COVID-19 vaccine acceptance. Statistical analyses were performed and P-values less than 0.05 were considered statistically significant at a CI of 95%. Results showed that 59.3% of the participants were amenable to COVID-19 vaccines. Multinomial regression analysis identified 14 variables at α < 0.05 as predictors for vaccine acceptance. Male HCWs were 2.8 times more likely to accept the vaccine than their female counterparts. HCWs that were knowledgeable of the different kinds of vaccines, were willing to recommend the vaccines to their patients, believed that the timing of COVID-19 vaccination was appropriate and had recent vaccination history within three years were 1.6, 24.9, 4.4 and 3.1 times more likely to take COVID-19 vaccine than those not sure. The study found a relatively high trust (51.3%) in the Nigerian Center for Disease Control (NCDC) for information regarding COVID-19 vaccines. Therefore, the NDCD should disseminate more robust insights regarding the safety profiles of various COVID-19 vaccines.
- Open Access
- 1 September 2022
- Published by MDPI AG in Preprints.org
Predictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria
Healthcare workers (HCWs) are regarded as role models regarding health-related issues including vaccination. Therefore, it is essential to identify the predictors for COVID-19 vaccine acceptance among them. A cross-sectional study to assess the risk perception, attitudes and knowledge of HCWs toward COVID-19 vaccination was carried out. A total of 710 responses were received between September 2021 to March 2022, from HCWs in the Northern, Western and Eastern regions of Nigeria. Cross tabulations were performed to determine statistical relations between sociodemographic variables, knowledge, attitudes and risk perceptions concerning COVID-19 vaccine acceptance. Multinomial Logistic Regression analysis was performed to determine the predictive variables for COVID-19 vaccine acceptance. Statistical analyses were performed and P-values less than 0.05 were considered statistically significant at a CI of 95%. Results showed that 59.3% of the participants were amenable to COVID-19 vaccines. Multinomial regression analysis identified 14 variables at α <0.05 as predictors for vaccine acceptance. Male HCWs were 2.8 times more likely to accept the vaccine than their female counterparts. HCWs that were knowledgeable of the different kinds of vaccines, willing to recommend the vaccines to their patients, believe that the timing of COVID-19 vaccination was appropriate and had recent vaccination history within three years were 1.6, 24.9, 4.4 and 3.1 times more likely to take COVID-19 vaccine than those not sure. The study found a relatively high trust (51.3%) in the Nigerian Center for Disease Control (NCDC) for information regarding COVID-19 vaccines. Therefore, the NDCD should disseminate more robust insights regarding the safety profiles of various COVID-19 vaccines.
- 1 September 2022
- Published by MDPI AG in Preprints.org
Open AccessPredictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria
Healthcare workers (HCWs) are regarded as role models regarding health-related issues including vaccination. Therefore, it is essential to identify the predictors for COVID-19 vaccine acceptance among them. A cross-sectional study to assess the risk perception, attitudes and knowledge of HCWs toward COVID-19 vaccination was carried out. A total of 710 responses were received between September 2021 to March 2022, from HCWs in the Northern, Western and Eastern regions of Nigeria. Cross tabulations were performed to determine statistical relations between sociodemographic variables, knowledge, attitudes and risk perceptions concerning COVID-19 vaccine acceptance. Multinomial Logistic Regression analysis was performed to determine the predictive variables for COVID-19 vaccine acceptance. Statistical analyses were performed and P-values less than 0.05 were considered statistically significant at a CI of 95%. Results showed that 59.3% of the participants were amenable to COVID-19 vaccines. Multinomial regression analysis identified 14 variables at α <0.05 as predictors for vaccine acceptance. Male HCWs were 2.8 times more likely to accept the vaccine than their female counterparts. HCWs that were knowledgeable of the different kinds of vaccines, willing to recommend the vaccines to their patients, believe that the timing of COVID-19 vaccination was appropriate and had recent vaccination history within three years were 1.6, 24.9, 4.4 and 3.1 times more likely to take COVID-19 vaccine than those not sure. The study found a relatively high trust (51.3%) in the Nigerian Center for Disease Control (NCDC) for information regarding COVID-19 vaccines. Therefore, the NDCD should disseminate more robust insights regarding the safety profiles of various COVID-19 vaccines.
- Open Access
- 27 July 2022
- Published by Springer Nature in Research Square
COVID-19 Vaccine: Vaccine Acceptance, Risk Perception, and Attitude Towards Vaccination among College Students and Staff in the Southeastern Universities, Nigeria
University students occupy a strategic position in the spread of coronavirus disease 19 (COVID-19) as they regularly travel around different locations with differing prevalence of the disease. This study was carried out to evaluate the acceptance of COVID-19 vaccines among university staffs and students in Southeastern universities of Nigeria. Self-administered anonymous online survey was conducted between 28th February and 30th June 2021, using various online social media handles. A total of 769 students and staff members participated in the study. Descriptive statistics for socio-demographics and other parameters were performed. The relationships between tested parameters were ascertained using bivariate Pearson’s correlation. Multiple linear regression analyses were done to determine associations. All statistical analyses were performed using IBM SPSS statistics 23 and P value < 0.05 was considered statistically significant at 95% CI. The respondents were 48.1% female and 51.9% male with a mean age of 24.4 years. The acceptance rate of COVID-19 vaccine was 25.6% and 82.2% of participants expressed concern about the side effects of the vaccine. While the age, gender and states of respondents were positively associated, their faculties were negatively associated with risk perception of COVID-19 vaccine. Also, the various faculties, university affiliations (P = 0.029), and age (P = 0.023) of the respondents were negatively associated, while the State of the respondents (P = 0.01) was positively associated with attitudes towards general COVID-19 vaccination. There is need for more robust information and better dissemination of such among the public to boost their confidence in COVID-19 vaccination.
- 27 July 2022
- Published by Springer Nature in Research Square
Open AccessCOVID-19 Vaccine: Vaccine Acceptance, Risk Perception, and Attitude Towards Vaccination among College Students and Staff in the Southeastern Universities, Nigeria
University students occupy a strategic position in the spread of coronavirus disease 19 (COVID-19) as they regularly travel around different locations with differing prevalence of the disease. This study was carried out to evaluate the acceptance of COVID-19 vaccines among university staffs and students in Southeastern universities of Nigeria. Self-administered anonymous online survey was conducted between 28th February and 30th June 2021, using various online social media handles. A total of 769 students and staff members participated in the study. Descriptive statistics for socio-demographics and other parameters were performed. The relationships between tested parameters were ascertained using bivariate Pearson’s correlation. Multiple linear regression analyses were done to determine associations. All statistical analyses were performed using IBM SPSS statistics 23 and P value < 0.05 was considered statistically significant at 95% CI. The respondents were 48.1% female and 51.9% male with a mean age of 24.4 years. The acceptance rate of COVID-19 vaccine was 25.6% and 82.2% of participants expressed concern about the side effects of the vaccine. While the age, gender and states of respondents were positively associated, their faculties were negatively associated with risk perception of COVID-19 vaccine. Also, the various faculties, university affiliations (P = 0.029), and age (P = 0.023) of the respondents were negatively associated, while the State of the respondents (P = 0.01) was positively associated with attitudes towards general COVID-19 vaccination. There is need for more robust information and better dissemination of such among the public to boost their confidence in COVID-19 vaccination.
- Open Access
- 1 June 2022
- Published by MDPI AG in Venereology
- Vol. 1 (1) , 124-134
Prevalence of Hepatitis B Virus Seromarkers in Female Sex Workers in Enugu State, Nigeria
Hepatitis B virus (HBV) is a sexually transmitted virus with a wide range of terminal complications. As such, female sex workers (FSWs) are an important group in the epidemiology of the virus. This study was aimed at evaluating the seroprevalence of HBV markers and the exposure rate of the virus among FSWs in Enugu State, Nigeria. A cross-sectional study was carried out among brothel-based FSWs, involving 200 participants recruited using a consecutive sampling method. Blood specimens were collected and tested for HBV markers using chromatographic immunoassay rapid test kits. Additional information was obtained through the administration of a well-structured pre-tested questionnaire. Data were entered into Statistical Package for Social Sciences (SPSS) version 20.0 and analyzed using the Descriptive Statistics and Chi-Square test in SPSS. Out of the 200 sampled individuals, 82(41%) tested positive for at least one seromarker, with 44(22%) showing evidence of natural infection and 38(19%) indicating a vaccine response. Hepatitis B core antibody (total anti-HBc) was present in 42(21%) of the participants, while 8(4%) had hepatitis B surface antigen (HBsAg), which is indicative of current infection. This study revealed intermediate prevalence, a high exposure rate and a low vaccination rate among the study population. There is a need for more effective intervention strategies among FSWs in the study area.
- 1 June 2022
- Published by MDPI AG in Venereology
- Vol. 1 (1) , 124-134
Open AccessPrevalence of Hepatitis B Virus Seromarkers in Female Sex Workers in Enugu State, Nigeria
Hepatitis B virus (HBV) is a sexually transmitted virus with a wide range of terminal complications. As such, female sex workers (FSWs) are an important group in the epidemiology of the virus. This study was aimed at evaluating the seroprevalence of HBV markers and the exposure rate of the virus among FSWs in Enugu State, Nigeria. A cross-sectional study was carried out among brothel-based FSWs, involving 200 participants recruited using a consecutive sampling method. Blood specimens were collected and tested for HBV markers using chromatographic immunoassay rapid test kits. Additional information was obtained through the administration of a well-structured pre-tested questionnaire. Data were entered into Statistical Package for Social Sciences (SPSS) version 20.0 and analyzed using the Descriptive Statistics and Chi-Square test in SPSS. Out of the 200 sampled individuals, 82(41%) tested positive for at least one seromarker, with 44(22%) showing evidence of natural infection and 38(19%) indicating a vaccine response. Hepatitis B core antibody (total anti-HBc) was present in 42(21%) of the participants, while 8(4%) had hepatitis B surface antigen (HBsAg), which is indicative of current infection. This study revealed intermediate prevalence, a high exposure rate and a low vaccination rate among the study population. There is a need for more effective intervention strategies among FSWs in the study area.
- 5 June 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 60-68
Seroprevalence of Hepatitis B and C Viruses, and HIV among Antenatal Pregnant Women in Nsukka, Enugu State, Nigeria
Aim: Hepatitis B and C viruses and HIV infections remain major global health concerns as causes of high morbidity and mortality in developing countries. This study aimed at determining the prevalence of HBsAg antibody, anti-Hepatitis C and HIV 1 and 2 antibodies in antenatal pregnant women in Nsukka, Nigeria. Study Design, Area and Duration of Study: The study utilized both experimental and survey designs. Blood samples were collected from women attending antenatal clinics in two prominent hospitals in Nsukka, Enugu State, Nigeria from April to August 2016. Methods: Blood samples from 200 pregnant women were collected into plain vacutainers and allowed to clot. The serum was separated and used to test for antibodies to the viral infections using rapid test kits with immobilized antigens following the manufacturer’s instructions. Additional information was collected using standard questionnaire. Results: From the results, 11 (5.5%), 9 (4.5%) and 5 (2.5%) women tested positive for HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies, respectively. None of the patients was co-infected with HBV/HCV, HBV/HIV, HCV/HIV or triple infections with HBV/HCV/HIV. The mean age distribution was 28.2 years (Standard Deviation = 6.46). Marital status, age distribution and occupation were found to be statistically insignificant to the prevalence of HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies (P > 0.05). Blood transfusion and history of previous surgeries were the risk factors for HBsAg and HIV 1 and 2 antibodies (P < 0.05), but not for anti- HCV (P> 0.05) among the study population. None of the respondents had body tattoo or admitted to have multiple sexual partners. Conclusion: There are still high seroprevalence of HBV, HCV and HIV among antenatal pregnant women in the study area. Hence, there is need for integration of hepatitis screening tests among the antenatal pregnant women in the town.
- 5 June 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 60-68
Seroprevalence of Hepatitis B and C Viruses, and HIV among Antenatal Pregnant Women in Nsukka, Enugu State, Nigeria
Aim: Hepatitis B and C viruses and HIV infections remain major global health concerns as causes of high morbidity and mortality in developing countries. This study aimed at determining the prevalence of HBsAg antibody, anti-Hepatitis C and HIV 1 and 2 antibodies in antenatal pregnant women in Nsukka, Nigeria. Study Design, Area and Duration of Study: The study utilized both experimental and survey designs. Blood samples were collected from women attending antenatal clinics in two prominent hospitals in Nsukka, Enugu State, Nigeria from April to August 2016. Methods: Blood samples from 200 pregnant women were collected into plain vacutainers and allowed to clot. The serum was separated and used to test for antibodies to the viral infections using rapid test kits with immobilized antigens following the manufacturer’s instructions. Additional information was collected using standard questionnaire. Results: From the results, 11 (5.5%), 9 (4.5%) and 5 (2.5%) women tested positive for HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies, respectively. None of the patients was co-infected with HBV/HCV, HBV/HIV, HCV/HIV or triple infections with HBV/HCV/HIV. The mean age distribution was 28.2 years (Standard Deviation = 6.46). Marital status, age distribution and occupation were found to be statistically insignificant to the prevalence of HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies (P > 0.05). Blood transfusion and history of previous surgeries were the risk factors for HBsAg and HIV 1 and 2 antibodies (P < 0.05), but not for anti- HCV (P> 0.05) among the study population. None of the respondents had body tattoo or admitted to have multiple sexual partners. Conclusion: There are still high seroprevalence of HBV, HCV and HIV among antenatal pregnant women in the study area. Hence, there is need for integration of hepatitis screening tests among the antenatal pregnant women in the town.